112 related articles for article (PubMed ID: 9152861)
1. Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system.
Bottone AE; de Beer EL; Voest EE
J Mol Cell Cardiol; 1997 Mar; 29(3):1001-8. PubMed ID: 9152861
[TBL] [Abstract][Full Text] [Related]
2. Impairment of the actin-myosin interaction in permeabilized cardiac trabeculae after chronic doxorubicin treatment.
Bottone AE; Voest EE; de Beer EL
Clin Cancer Res; 1998 Apr; 4(4):1031-7. PubMed ID: 9563899
[TBL] [Abstract][Full Text] [Related]
3. Persistent effects of doxorubicin on cardiac gene expression.
Boucek RJ; Miracle A; Anderson M; Engelman R; Atkinson J; Dodd DA
J Mol Cell Cardiol; 1999 Aug; 31(8):1435-46. PubMed ID: 10423342
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin impairs crossbridge turnover kinetics in skinned cardiac trabeculae after acute and chronic treatment.
de Beer EL; Bottone AE; van Der Velden J; Voest EE
Mol Pharmacol; 2000 Jun; 57(6):1152-7. PubMed ID: 10825385
[TBL] [Abstract][Full Text] [Related]
5. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
6. Dexrazoxane pre-treatment protects skinned rat cardiac trabeculae against delayed doxorubicin-induced impairment of crossbridge kinetics.
de Beer EL; Bottone AE; van Rijk MC; van der Velden J; Voest EE
Br J Pharmacol; 2002 Apr; 135(7):1707-14. PubMed ID: 11934811
[TBL] [Abstract][Full Text] [Related]
7. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats.
Zhou S; Heller LJ; Wallace KB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):60-7. PubMed ID: 11509027
[TBL] [Abstract][Full Text] [Related]
8. The role of biotransformation in anthracycline-induced cardiotoxicity in mice.
de Jong J; Schoofs PR; Snabilié AM; Bast A; van der Vijgh WJ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1312-20. PubMed ID: 8371139
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline-induced tension in permeabilized cardiac fibers: evidence for the activation of the calcium release channel of sarcoplasmic reticulum.
Boucek RJ; Buck SH; Scott F; Oquist NL; Fleischer S; Olson RD
J Mol Cell Cardiol; 1993 Mar; 25(3):249-59. PubMed ID: 8389887
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity of anthracyclines.
Bossa R; Efstathiu G; Galatulas I; Nilnci MA
In Vivo; 1991; 5(1):61-3. PubMed ID: 1932627
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase A increases the tension cost and unloaded shortening velocity in skinned rat cardiac muscle.
Saeki Y; Kobayashi T; Minamisawa S; Sugi H
J Mol Cell Cardiol; 1997 Jun; 29(6):1655-63. PubMed ID: 9220351
[TBL] [Abstract][Full Text] [Related]
12. Length modulation of active force in rat cardiac myocytes: is titin the sensor?
Cazorla O; Vassort G; Garnier D; Le Guennec JY
J Mol Cell Cardiol; 1999 Jun; 31(6):1215-27. PubMed ID: 10371696
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
14. A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle.
Gross T; Lues I; Daut J
J Mol Cell Cardiol; 1993 Mar; 25(3):239-44. PubMed ID: 8510167
[TBL] [Abstract][Full Text] [Related]
15. Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.
Minotti G; Cavaliere AF; Mordente A; Rossi M; Schiavello R; Zamparelli R; Possati G
J Clin Invest; 1995 Apr; 95(4):1595-605. PubMed ID: 7706466
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
[TBL] [Abstract][Full Text] [Related]
17. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
[TBL] [Abstract][Full Text] [Related]
18. Effects of rapamycin on cardiac and skeletal muscle contraction and crossbridge cycling.
Schoffstall B; Kataoka A; Clark A; Chase PB
J Pharmacol Exp Ther; 2005 Jan; 312(1):12-8. PubMed ID: 15306636
[TBL] [Abstract][Full Text] [Related]
19. Experimental study of dexrazoxane-anthracycline combinations using the model of isolated perfused rat heart.
Plandé J; Platel D; Tariosse L; Robert J
Toxicol Lett; 2006 Feb; 161(1):37-42. PubMed ID: 16129573
[TBL] [Abstract][Full Text] [Related]
20. Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue.
Minotti G; Parlani M; Salvatorelli E; Menna P; Cipollone A; Animati F; Maggi CA; Manzini S
Br J Pharmacol; 2001 Nov; 134(6):1271-8. PubMed ID: 11704647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
